We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.41B
AUM Growth
+$131M
(+3.1%)
Cap. Flow
-$472M
Cap. Flow
% of AUM
-10.71%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
983
New
316
Increased
242
Reduced
174
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$145M |
| 2 |
Amgen
AMGN
|
+$84.8M |
| 3 |
Perrigo
PRGO
|
+$60.8M |
| 4 |
Tenet Healthcare
THC
|
+$53.5M |
| 5 |
Cardinal Health
CAH
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$132M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$80.9M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$65M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$65M |
| 5 |
Gilead Sciences
GILD
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.02% |
| 2 | Consumer Staples | 4.24% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Industrials | 3.96% |
| 5 | Utilities | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESV
501
DELISTED
Ensco Rowan plc
ESV
| $602K | 0.01% |
+2,800
| New | +$642K |
|
502
Cleveland-Cliffs
CLF
$6.57B
| $600K | 0.01% |
+29,292
| New | +$603K |
|
503
West Pharmaceutical
WST
$24B
| $599K | 0.01% |
14,548
+1,980
| +16% | +$75.5K |
|
|
RTN
504
DELISTED
Raytheon Company
RTN
| $597K | 0.01% |
+7,740
| New | +$574K |
|
|
S
505
DELISTED
Sprint Corporation
S
| $597K | 0.01% |
+96,059
| New | +$632K |
|
506
RH
RH
$3.13B
| $594K | 0.01% |
+9,377
| New | +$647K |
|
507
Southern Company
SO
$109B
| $589K | 0.01% |
14,300
+8,692
| +155% | +$374K |
|
508
Consolidated Edison
ED
$40.1B
| $587K | 0.01% |
10,640
+6,471
| +155% | +$373K |
|
|
MHGC
509
DELISTED
Morgans Hotel Group Co.
MHGC
| $587K | 0.01% |
76,281
-20,998
| -22% | -$150K |
|
|
STR
510
DELISTED
QUESTAR CORP
STR
| $586K | 0.01% |
+26,040
| New | +$601K |
|
|
SPLS
511
DELISTED
Staples Inc
SPLS
| $585K | 0.01% |
+39,903
| New | +$626K |
|
512
Target
TGT
$65.6B
| $582K | 0.01% |
+9,101
| New | +$620K |
|
|
VIVS
513
VivoSim Labs
VIVS
$1.2M
| $577K | 0.01% |
+417
| New | +$582K |
|
|
HSTO
514
DELISTED
Histogen Inc. Common Stock
HSTO
| $577K | 0.01% |
+287
| New | +$533K |
|
|
ICEL
515
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
| $571K | 0.01% |
+31,000
| New | +$467K |
|
516
Hasbro
HAS
$13.2B
| $568K | 0.01% |
+12,058
| New | +$563K |
|
|
UNT
517
DELISTED
UNIT Corporation
UNT
| $567K | 0.01% |
+12,200
| New | +$560K |
|
518
Lincoln National
LNC
$8.73B
| $561K | 0.01% |
+13,356
| New | +$564K |
|
519
CALL
BlackBerry
BB
$4.98B
| $558K | 0.01% |
+702
| New | +$6.82K |
|
520
Coca-Cola Femsa
KOF
$22.7B
| $556K | 0.01% |
4,411
-1,243
| -22% | -$171K |
|
521
Public Service Enterprise Group
PEG
$38.2B
| $555K | 0.01% |
16,845
+9,436
| +127% | +$312K |
|
522
Everest Group
EG
$14.5B
| $553K | 0.01% |
+3,800
| New | +$515K |
|
|
IRF
523
DELISTED
INTL RECTIFIER CORP
IRF
| $550K | 0.01% |
+22,210
| New | +$537K |
|
|
PEO
524
Adams Natural Resources Fund
PEO
$739M
| $537K | 0.01% |
20,626
+153
| +0.7% | +$3.93K |
|
525
Louisiana-Pacific
LPX
$5.06B
| $535K | 0.01% |
30,403
-27,406
| -47% | -$453K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, Visium Asset Management held 983 positions worth $4.41B, up 3.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management withdrew a net $472M in Q3 2013, closing 237 positions and reducing 174 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Visium Asset Management opened a new position in Brookdale Senior Living worth $37.5M.
- Visium Asset Management's largest Q3 2013 buy was Brookdale Senior Living: 1,426,060 shares worth $37.5M.
- Visium Asset Management added most to Allergan Inc in Q3 2013, an estimated $145M increase.
- Visium Asset Management's biggest Q3 2013 reduction was Endo International plc, cutting an estimated $80.9M.
- Visium Asset Management fully exited Bausch Health in Q3 2013, selling an estimated $132M.
- Visium Asset Management's ten largest holdings make up 32% of its $4.41B portfolio in Q3 2013.
- Visium Asset Management opened 316 new positions and closed 237 in Q3 2013.
- Visium Asset Management's portfolio value rose 3.1% quarter-over-quarter to $4.41B.
Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.